Tonix Pharmaceutics Holdings Inc. (TNXP) stock gains during current market. What’s driving it high?
Tonix Pharmaceuticals Holdings Inc. (TNXP) stock gains by 2.81% in the current market trading session. Tonix is a clinical-stage biopharmaceutical business dedicated on finding, licensing, purchasing, and developing small molecules and biologics to cure, prevent, and relieve human illness. Tonix’s portfolio is largely made up of pharmaceutical candidates for the central nervous system and immunology. […]
Tonix Pharmaceuticals Inc. (TNXP) stock soars during pre-market trading. Let’s find out why?
Tonix Pharmaceuticals Inc. (NASDAQ: TNXP) stock gained by 5.65% at the last close while the TNXP stock price rises by 3.82% in the pre-market trading session. Tonix is a clinical-stage pharmaceutical business dedicated on finding, licensing, purchasing, and developing small molecules and biologics to cure, prevent, and relieve human illness. Tonix’s portfolio is mostly made […]
Is that how Tonix Pharmaceuticals (TNXP) surged in the Premarket today?
Tonix Pharmaceuticals Holding Corp. (TNXP) shares go up more than 28% to $0.849 in the premarket trading session after it revealed the closing of the purchase of a 44-acre site in Hamilton, Montana, that will be used to develop and manufacture vaccines. In September 2020, Tonix entered into a lease agreement to purchase 40,000 square […]